Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. bras. farmacogn ; 22(1): 69-75, Jan.-Feb. 2012. tab
Artigo em Inglês | LILACS | ID: lil-607591

RESUMO

The chemical composition of the essential oil obtained from the fresh and dried leaves of Lippia gracillis Schauer, Verbenaceae, was analyzed by gas chromatography and gas chromatography/mass spectrometry (GC⁄MS). The yield of essential oil extracted from the dried leaves was significantly higher (p<0.05) when compared to the fresh leaves. Seventeen components were identified. The monoterpenes and sesquiterpene hydrocarbons with 96.26 percent (w/w) of the total oil obtained of fresh leaves and 86.99 percent (w/w) of the total oil obtained of dried leaves were the principal compound groups. Thymol was observed dominant (44.42 percent; 21.3 percent), followed by carvacrol (22.21 percent; 21.30 percent), p-cymene (6.23 percent; 8.58 percent), α-pinene (5.65 percent; 19.42 percent), β-caryophyllene (5.61 percent; 3.57 percent) and other minor constitutes, respectively. Microbiological results obtained by agar diffusion method, micro dilution method and minimum inhibitory concentration (MIC) showed that the essential oil has a relevant antimicrobial activity against E. coli (ATCC 10536), E. coli (Ec 27), Pseudomonas aeruginosa (ATCC 15442), S. aureus (ATCC 12692) and S. aureus (Sa 358), with their inhibition zones ranging from 9 to 13 mm and the MIC ranging from 64 to 512 μg/mL.

2.
J. epilepsy clin. neurophysiol ; 13(4): 169-175, Dec. 2007. tab
Artigo em Português | LILACS | ID: lil-476672

RESUMO

INTRODUÇÃO: A epilepsia é um transtorno neurológico que chega a afetar cerca de 1 por cento da população mundial. Muitas formas de epilepsias não conseguem ser tratadas adequadamente com os fármacos atualmente utilizados na clínica e o desenvolvimento de novas propostas terapêuticas que as tratem, não apenas de forma sintomática, mas em sua gênese, é uma busca constante de novos estudos. OBJETIVO E DISCUSSÃO: Nesse sentido, a presente revisão busca fazer um breve levantamento sobre os aspectos científicos mais consistentes acerca do papel dos canais iônicos no desenvolvimento das epilepsias, bem como correlacionar com o estudo de drogas antiepilépticas (DAEs) e mostrar as principais características farmacológicas das DAEs mais utilizadas na clínica atualmente. O papel dos canais de Na+ e Ca+2 como alvo de novas DAEs e a participação de outros receptores nesse processo são igualmente discutidos. CONCLUSÃO: A compreensão da fisiopatologia das epilepsias e dos possíveis alvos moleculares para novos fármacos é um dos principais focos para o descobrimento de tratamentos mais eficazes e com menos efeitos adversos.


INTRODUCTION: Current epidemiological studies show a prevalence rate for active epilepsy in 0,5-1 percent of the population. Many forms of epilepsy are intractable to current therapies and there is a pressing need to develop agents and strategies to not only suppress seizures, but also cure epilepsy. OBJECTIVE AND DISCUSSION: The aim of this review was to the recent advances in the physiology of ion channels and other potential molecular targets, in conjunction with new informations on the genetics of idiopathic epilepsies, and current antiepileptic drugs (AEDs). Marketed AEDs predominantly target voltage-gated cation channels (the a-subunits of voltage gated Na+ channels and also T-type voltage-gated Ca2+ channels) or influence GABA-mediated inhibition. CONCLUSION: The growing understanding of the pathophysiology of epilepsy and the structural and functional characterization of the molecular targets provide many opportunities to create improved epilepsy therapies.


Assuntos
Humanos , Canais de Sódio , Epilepsia/tratamento farmacológico , Canais Iônicos , Anticonvulsivantes/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA